Diabetes 51:3069-3076, 2002
© 2002 by the American Diabetes Association, Inc.
Risk Factor Groupings Related to Insulin Resistance and Their Synergistic Effects on Subclinical Atherosclerosis
The Atherosclerosis Risk in Communities Study
Sherita Hill Golden1,
Aaron R. Folsom2,
Josef Coresh3,
A. Richey Sharrett4,
Moyses Szklo3, and
Frederick Brancati1,3
1 Department of Medicine, the Johns Hopkins Medical Institutions, Baltimore, Maryland
2 Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota
3 Department of Epidemiology, the Johns Hopkins Medical Institutions, Baltimore, Maryland
4 National Heart, Lung, and Blood Institute, Bethesda, Maryland
The extent to which groupings of insulin resistance-related cardiovascular risk factors synergize to produce atherosclerosis beyond what is expected from their additive effects is uncertain. The objective of this study was to measure interactions among groupings of the features of the insulin resistance syndrome (IRS) on carotid intimal-medial thickness (IMT). This cross-sectional study used baseline data from the Atherosclerosis Risk in Communities Study on 11,790 adults aged 4564 years without diagnosed diabetes, treated dyslipidemia, or coronary heart disease. The main outcome was carotid IMT, assessed using B-mode ultrasound. The excess carotid IMT attributable to each IRS grouping was determined using multiple linear regression models. There were 57 possible combinations of six IRS components (hypertension, hyperinsulinemia, obesity, hypertriglyceridemia, low HDL cholesterol, and hyperglycemia). In multivariate analysis, 29 of the 57 groupings were associated with excess carotid IMT. Individuals with all six IRS components had the greatest excess IMT compared with those without this grouping (71 µm; 95% CI 40102 µm). The groupings most strongly associated with excess carotid IMT included hypertension and hypertriglyceridemia. Interventions aimed at ameliorating the IRS may produce reductions in atherosclerotic risk beyond that predicted by treatment of individual IRS-related risk factors.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Vaidya, M. Szklo, K. Liu, P. J. Schreiner, A. G. Bertoni, and P. Ouyang
Defining the Metabolic Syndrome Construct: Multi-Ethnic Study of Atherosclerosis (MESA) cross-sectional analysis
Diabetes Care,
August 1, 2007;
30(8):
2086 - 2090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Arenillas, M. A. Moro, and A. Davalos
The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Stroke,
July 1, 2007;
38(7):
2196 - 2203.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kahn
Metabolic Syndrome: Is It a Syndrome? Does It Matter?
Circulation,
April 3, 2007;
115(13):
1806 - 1811.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Amano, T. Matsubara, T. Uetani, M. Nanki, N. Marui, M. Kato, K. Arai, K. Yokoi, H. Ando, H. Ishii, et al.
Impact of Metabolic Syndrome on Tissue Characteristics of Angiographically Mild to Moderate Coronary Lesions: Integrated Backscatter Intravascular Ultrasound Study
J. Am. Coll. Cardiol.,
March 20, 2007;
49(11):
1149 - 1156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Estrada-Smith, A. R. Collins, X. Wang, C. Crockett, L. Castellani, A. J. Lusis, and R. C. Davis
Impact of Chromosome 2 Obesity Loci on Cardiovascular Complications of Insulin Resistance in LDL Receptor-Deficient C57BL/6 Mice.
Diabetes,
August 1, 2006;
55(8):
2265 - 2271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kahn
The Metabolic Syndrome (Emperor) Wears No Clothes
Diabetes Care,
July 1, 2006;
29(7):
1693 - 1696.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Abdelghaffar, M. El Amir, A. El Hadidi, and F. El Mougi
Carotid Intima-Media Thickness: An Index for Subclinical Atherosclerosis in Type 1 Diabetes
J Trop Pediatr,
February 1, 2006;
52(1):
39 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W.F. Wilson, R. B. D'Agostino, H. Parise, L. Sullivan, and J. B. Meigs
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
Circulation,
November 15, 2005;
112(20):
3066 - 3072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Lawlor, M. J. O'Callaghan, A. A. Mamun, G. M. Williams, W. Bor, and J. M. Najman
Socioeconomic Position, Cognitive Function, and Clustering of Cardiovascular Risk Factors in Adolescence: Findings From the Mater University Study of Pregnancy and Its Outcomes
Psychosom Med,
November 1, 2005;
67(6):
862 - 868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kahn, J. Buse, E. Ferrannini, and M. Stern
The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care,
September 1, 2005;
28(9):
2289 - 2304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Burchfiel, T. N. Skelton, M. E. Andrew, R. J. Garrison, D. K. Arnett, D. W. Jones, and H. A. Taylor Jr
Metabolic Syndrome and Echocardiographic Left Ventricular Mass in Blacks: The Atherosclerosis Risk in Communities (ARIC) Study
Circulation,
August 9, 2005;
112(6):
819 - 827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Janssen
Heart disease risk among metabolically healthy obese men and metabolically unhealthy lean men
Can. Med. Assoc. J.,
May 10, 2005;
172(10):
1315 - 1316.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. McNeill, W. D. Rosamond, C. J. Girman, S. H. Golden, M. I. Schmidt, H. E. East, C. M. Ballantyne, and G. Heiss
The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study
Diabetes Care,
February 1, 2005;
28(2):
385 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Raikkonen, K. A. Matthews, K. Sutton-Tyrrell, and L. H. Kuller
Trait Anger and the Metabolic Syndrome Predict Progression of Carotid Atherosclerosis in Healthy Middle-Aged Women
Psychosom Med,
November 1, 2004;
66(6):
903 - 908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sugita, H. Sugita, and M. Kaneki
Increased Insulin Receptor Substrate 1 Serine Phosphorylation and Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase Activation Associated With Vascular Insulin Resistance in Spontaneously Hypertensive Rats
Hypertension,
October 1, 2004;
44(4):
484 - 489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Golden, J. Ding, M. Szklo, M. I. Schmidt, B. B. Duncan, and A. Dobs
Glucose and Insulin Components of the Metabolic Syndrome Are Associated with Hyperandrogenism in Postmenopausal Women: The Atherosclerosis Risk in Communities Study
Am. J. Epidemiol.,
September 15, 2004;
160(6):
540 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Y. Wong, B. B. Duncan, S. H. Golden, R. Klein, D. J. Couper, B. E. K. Klein, L. D. Hubbard, A. R. Sharrett, and M. I. Schmidt
Associations between the Metabolic Syndrome and Retinal Microvascular Signs: The Atherosclerosis Risk in Communities Study
Invest. Ophthalmol. Vis. Sci.,
September 1, 2004;
45(9):
2949 - 2954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Lawlor, S. Ebrahim, M. May, and G. Davey Smith
(Mis)use of Factor Analysis in the Study of Insulin Resistance Syndrome
Am. J. Epidemiol.,
June 1, 2004;
159(11):
1013 - 1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ebrahim, D. Montaner, and D. A Lawlor
Clustering of risk factors and social class in childhood and adulthood in British women's heart and health study: cross sectional analysis
BMJ,
April 10, 2004;
328(7444):
861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B Meigs
The metabolic syndrome
BMJ,
July 10, 2003;
327(7406):
61 - 62.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Tack
Insulin Resistance and Acute Cardiovascular Complications
Seminars in Cardiothoracic and Vascular Anesthesia,
March 1, 2003;
7(1):
85 - 90.
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|